SCHEMBL14466515

SCHEMBL14466515

CCc1ccc(OC)cc1C(C)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
HPGD P15428 2/20 0.58
CYP3A4 P08684 2/20 0.58
MAPK1 P28482 1/20 0.58
MAPT P10636 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 3/20 0.46
GAA P10253 1/20 0.46
MAOB P27338 1/20 0.46
POLB P06746 1/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
HSD17B10 Q99714 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HSP90AA1 P07900 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14864226 0.87 ALDH1A1 (0.56) ALDH1A1HPGDCYP3A4MAPK1MAPT
SCHEMBL16951695 0.87 CYP3A4 (0.46) ALDH1A1HPGDCYP3A4MAPK1MAPT
SCHEMBL10112008 0.86 ALDH1A1 (0.54) ALDH1A1HPGDCYP3A4MAPK1MAPT
SCHEMBL13469239 0.85 SMN1; SMN2 (0.57) ALDH1A1HPGDMAPTKMT2AKDM4E
SCHEMBL12328328 0.85 KDM4E (0.50) ALDH1A1HPGDCYP3A4MAPK1MAPT
SCHEMBL5730634 0.85 ALDH1A1 (0.62) ALDH1A1HPGDCYP3A4MAPK1MAPT
SCHEMBL7314126 0.84 HSD17B10 (0.61) ALDH1A1HPGDCYP3A4MAPK1MAPT
SCHEMBL17570761 0.84 CYP3A4 (0.44) ALDH1A1HPGDCYP3A4MAPK1MAPT
SCHEMBL16238926 0.84 POLB (0.45) ALDH1A1HPGDCYP3A4MAPK1MAPT
SCHEMBL13469244 0.84 KDM4E (0.58) ALDH1A1HPGDCYP3A4MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1973901-B1 HYDANTOIN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISORDERS MERCK SHARP & DOHME (US) 2014-12-17 EP disclosed
WO-2007084415-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2007-07-26 WO disclosed